JANUX THERAPEUTICS INC's ticker is JANX and the CUSIP is 47103J105. A total of 49 filers reported holding JANUX THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $92,389,772 | -10.2% | 9,165,652 | +5.7% | 1.82% | -6.4% |
| Q2 2023 | $102,920,544 | -1.9% | 8,670,644 | 0.0% | 1.94% | -18.2% |
| Q1 2023 | $104,914,792 | -8.1% | 8,670,644 | 0.0% | 2.38% | +2.5% |
| Q4 2022 | $114,192,381 | -2.7% | 8,670,644 | 0.0% | 2.32% | -7.5% |
| Q3 2022 | $117,401,000 | +10.9% | 8,670,644 | 0.0% | 2.50% | -11.3% |
| Q2 2022 | $105,869,000 | -14.9% | 8,670,644 | 0.0% | 2.82% | +4.1% |
| Q1 2022 | $124,337,000 | -27.3% | 8,670,644 | 0.0% | 2.71% | -10.0% |
| Q4 2021 | $171,072,000 | -8.8% | 8,670,644 | 0.0% | 3.02% | +16.0% |
| Q3 2021 | $187,546,000 | -13.3% | 8,670,644 | 0.0% | 2.60% | -25.1% |
| Q2 2021 | $216,333,000 | – | 8,670,644 | – | 3.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 8,670,644 | $104,914,792 | 2.38% |
| EcoR1 Capital, LLC | 3,838,486 | $46,445,681 | 1.50% |
| Samsara BioCapital, LLC | 360,414 | $4,361,009 | 0.90% |
| BVF INC/IL | 1,585,677 | $19,186,692 | 0.70% |
| Orbimed Advisors | 2,836,386 | $34,320,271 | 0.67% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 900,000 | $10,890,000 | 0.02% |
| Woodline Partners LP | 137,300 | $1,661,330 | 0.02% |
| Vident Investment Advisory, LLC | 55,483 | $671,344 | 0.02% |
| JANUS HENDERSON GROUP PLC | 1,869,076 | $22,611,527 | 0.02% |
| FMR LLC | 10,281,288 | $124,403,584 | 0.01% |